Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Yang, Zhi Hong ^a   Miyahara, Hiroko ^a   Takeo, Jiro ^a   Hatanaka, Akimasa ^a   Katayama, Masashi ^a  

^a NIPPON SUISAN KAISHA LTD   (Japan)

Author keywords

adipokines; hepatic steatosis; hyperlipidemia; MUFA; n 3 PUFA; Pollock oil

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN B; CHOLESTEROL; EDIBLE OIL; FAS ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LARD; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; POLLOCK OIL; RESISTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ACYL COENZYME A DESATURASE; ADIPONECTIN, MOUSE; FATTY ACID SYNTHASE; FISH OIL; MESSENGER RNA; RETN PROTEIN, MOUSE; SCD1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CALORIC INTAKE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY LIVER; GENE EXPRESSION; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPOGENESIS; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DIET THERAPY; DOWN REGULATION; ENZYMOLOGY; FAT INTAKE; GADIFORMES; GENETICS; INTRAABDOMINAL FAT; LIPID METABOLISM; LIVER; METABOLISM; RANDOMIZATION;

MUS; POLLACHIUS;

ADIPONECTIN; ANIMALS; DIETARY FATS; DOWN-REGULATION; FATTY ACID SYNTHETASE COMPLEX; FATTY LIVER; FISH OILS; GADIFORMES; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERLIPIDEMIAS; INTRA-ABDOMINAL FAT; LEPTIN; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RESISTIN; RNA, MESSENGER; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEINS;

EID: 80054860007     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-189     Document Type: Article

References (34)

1. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Holvoet P, Verh K Acad Geneeskd Belg 2008 70 193 219 18669160
2. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. Meydani M, J Nutr 2001 131 366S 368S 11160562 (Pubitemid 32115382)
3. Effects of nutrients on postprandial lipemia. Lairon D, Defoort C, Curr Vasc Pharmacol 2011 9 309 312 10.2174/157016111795495576 21314626
4. n-3 Fatty acids and heart disease. Connor WE, Nutrition and disease update: heart disease Champaign, IL: American Oil Chemists' Society, Kritchevsky D, Carroll KK, 1994 7 42
5. Beneficial effects of dietary fish-oil-derived monounsaturated fatty acids on metabolic syndrome risk factors and insulin resistance in mice. Yang ZH, Miyahara H, Mori T, Doisaki N, Hatanaka A, J Agric Food Chem 2011 59 7482 7489 10.1021/jf201496h 21627145
6. Lipid composition of Alaska pink salmon (Oncorhynchus gorbuscha) and Alaska walleye pollock (theragra chalcogramma). Oliveira ACM, Bechtel PJ, J Aquat Food Prod Tech 2005 14 73 91 10.1300/J030v14n01-07 (Pubitemid 41249225)
7. Population Ecology and Structural Dynamics of Walleye Pollock (Theragra chalcogramma). Bailey KM, Powers DM, Quattro JM, Villa G, Nishimura A, Traynor JJ, Walters G, Dynamics of the Bering Sea 1999 581 614
8. Technology of production and industrial utilization of marine oil. Bimbo AP, Marine biogenic lipids, fats, and oil Boca, Raton, Florida: CRC Press, Inc, RG Ackman, 1989 II 401 433
9. A simple method for the isolation and purification of total lipids from animal tissues. Folch J, Lees M, Stanley GHS, J Biol Chem 1956 226 497 509
10. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Heart, Lung, and Blood Institute, Obes Res 1998 6 Suppl 2 51S 209S 9813653
11. Adiponectin: more than just another fat cell hormone? Chandran M, Phillips SA, Ciaraldi T, Henry RR, Diabetes Care 2003 26 2442 2450 10.2337/diacare.26.8.2442 12882876 (Pubitemid 36993340)
12. Decreased plasma adiponectin concentrations in women with dyslipidemia. Matsubara M, Maruoka S, Katayose S, J Clin Endocrinol Metab 2002 87 2764 2769 10.1210/jc.87.6.2764 12050247 (Pubitemid 34655342)
13. Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low density lipoprotein particle size in young healthy men. Kazumi T, Kawaguchi A, Hirano T, Yoshino G, Metab Clin Exp 2004 53 589 593 10.1016/j.metabol.2003.12.008 15131762 (Pubitemid 38596530)
14. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Hulthe J, Hulten LM, Fagerberg B, Metab Clin Exp 2003 52 1612 1614 10.1016/S0026-0495(03)00313-5 14669165 (Pubitemid 38049281)
15. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB, Diabetes Care 2004 27 1680 1687 10.2337/diacare.27.7.1680 15220246 (Pubitemid 38857444)
16. Adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y, Circulation 2001 103 1057 1063 11222466 (Pubitemid 32200177)
17. Adiponectin, a new member of the family of soluble defence collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y, Blood 2000 96 1723 1732 10961870 (Pubitemid 30661055)
18. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, Maeda K, Nagaretani H, Kishida K, Maeda N, Nagasawa A, Funahashi T, Matsuzawa Y, Circulation 2004 109 2046 2049 10.1161/01.CIR.0000127953.98131.ED 15096450 (Pubitemid 38620209)
19. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Jovinge S, Hamsten A, Tornvall P, Proudler A, Bavenholm P, Ericsson CG, Godsland I, de Faire U, Nilsson J, Metabolism 1998 47 113 118 10.1016/S0026-0495(98) 90203-7 9440488 (Pubitemid 28086243)
20. Monocyte chemoattractant protein-1 in human atheromatous plaques. Nelken NA, Coughlin SR, Gordon D, Wilcox JN, J Clin Invest 1991 88 1121 1127 10.1172/JCI115411 1843454
21. Differential Impact of Familial Hypercholesterolemia and Combined Hyperlipidemia on Vascular Wall and Network Remodeling in Mice. Stapleton PA, Goodwill AG, James ME, D'Audiffret AC, Frisbee JC, Microcirculation 2010 17 47 58 10.1111/j.1549-8719.2009.00003.x 20141600
22. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Tilg H, Moschen AR, Nat Rev Immunol 2006 6 772 783 10.1038/nri1937 16998510 (Pubitemid 44453463)
23. Obese, a new mutation in the house mouse. Ingalls AM, Dickie MM, Snell GD, J Hered 1950 41 317 318 14824537
24. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Martin SS, Qasim A, Reilly MP, J Am Coll Cardiol 2008 52 1201 1210 10.1016/j.jacc.2008.05.060 18926322
25. Leptin and cardiovascular disease: response to therapeutic interventions. Koh KK, Park SM, Quon MJ, Circulation 2008 117 3238 3249 10.1161/ CIRCULATIONAHA.107.741645 18574061
26. The mechanisms of action of PPARs. Berger J, Moller DE, Annu Rev Med 2002 53 409 435 10.1146/annurev.med.53.082901.104018 11818483 (Pubitemid 34177889)
27. Nuclear receptor signaling and cardiac energetics. Huss JM, Kelly DP, Circ Res 2004 95 568 578 10.1161/01.RES.0000141774.29937.e3 15375023 (Pubitemid 39274371)
28. Metabolic alterations during inflammation and its modulation by central actions of omega-3 fatty acids. Das UN, Ramos EJ, Meguid MM, Curr Opin Clin Nutr Metab Care 2003 6 413 419 12806215 (Pubitemid 40684593)
29. n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Browning LM, Proc Nutr Soc 2003 62 447 453 10.1079/PNS2003252 14506893 (Pubitemid 36841620)
30. Lipoprotein metabolism: an overview. Shepherd J, Ann Acad Med Singapore 1992 21 106 113 1590643
31. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Tietge UJ, Boker KH, Bahr MJ, Weinberg S, Pichlmayr R, Schmidt HH, Manns MP, Hepatogastroenterology 1998 45 2255 2260 9951906 (Pubitemid 29055818)
32. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. Osborne TF, J Biol Chem 2000 275 32379 32382 10934219
33. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Goldstein JL, Rawson RB, Brown MS, Arch Biochem Biophys 2002 397 139 148 10.1006/abbi.2001.2615 11795864 (Pubitemid 34852273)
34. Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies. Burnett JR, Barrett PHR, Crit Rev Clin Lab Sci 2002 39 89 137 10.1080/10408360208951113 12014529 (Pubitemid 34492990)